InvestorsHub Logo
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

Re: revenue_monster post# 180107

Sunday, 06/15/2014 11:18:39 PM

Sunday, June 15, 2014 11:18:39 PM

Post# of 346054
revenuemonster: don't agree Cotara a niche product. Agree that glioblastomamultiforme is a niche cancer. If Cotara does dent in GBM it can easily be used off label, once approved for GBM, for any tumor >2 cm with necrotic central core. And there are plenty of oncologists who understand the chemistry and MOA of I131 (and plenty of non-operable solid cancers that size and bigger).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News